AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Hawaii

HB1337

Relating To Psilocybin.

Status

Did not pass; died when the session ended

2023 Session

IntroducedJan 25, 2023 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Amy Perruso (Democrat)
Type: Study/Task Force
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Establishes the Therapeutic Psilocybin Working Group.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: capitol.hawaii.gov

Legislative history

December 11, 2023
Carried over to 2024 Regular Session.
January 30, 2023
Referred
January 25, 2023
Introduced

Loading bill…